CSF1R and cancer: The most potent compound against FMS kinase was tested against a panel of 40 kinases including FMS, tested against a panel of 13 cancer cell lines of 3 different cancer types and HS 27 fibroblasts, and against bone marrow-derived macrophages (BMDM) in order to investigate its biological effects.